Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis

J Med Virol. 2006 May;78(5):683-92. doi: 10.1002/jmv.20593.

Abstract

A seroprevalence study was carried out of six different human pathogenic viruses, namely human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus (HTLV), human herpesvirus type 8 (HHV-8), and dengue virus among pregnant women and blood donors from rural (Nouna) and urban (Ouagadougou) Burkina Faso, West Africa. A total of 683 samples from blood donors (n = 191) and pregnant women (n = 492) were collected from both sites and screened for the different virus infection markers resulting in the following prevalence values for Nouna or Ouagadougou, respectively: HIV 3.6/4.6, anti-HBV core (anti-HBc) 69.6/76.4, HBV surface antigen (HBsAg)14.3/17.3, HCV 2.2/1.5, HTLV 1.4/0.5, HHV-8 11.5/13.5, dengue virus 26.3/36.5. Individuals aged > or =25 years were more likely to be infected with HIV than those below 24 years (P < 0.05). Infection with HIV increased the likelihood of co-infection with other viruses, such as HHV-8, HBV and HTLV. Co-infection studies involving five viruses (HBV-HBsAg, HHV-8, HIV, HCV, and HTLV) showed that 4.8% (33/683) of the studied population were dually infected, with HBsAg+ HHV-8 (13/33), HBsAg+HIV (8/33) and HIV+HHV-8 (8/33) being the most common co-infections. Of the population studied 0.6% (4/683) was triply infected, the most common infection being with HBV+HIV+HHV-8 (3/4). There was no difference in the prevalence of HIV, anti-HBc, HBsAg, HCV, HTLV, and HHV-8 either among blood donors or pregnant women in urban or rural setting, while dengue virus prevalence was relatively lower in rural (26.3%) than in urban (36.5%) Burkina Faso.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Blood Donors*
  • Burkina Faso / epidemiology
  • Comorbidity
  • Dengue / epidemiology*
  • Dengue Virus / immunology*
  • Female
  • HIV Antibodies / blood
  • HIV Infections / epidemiology*
  • HTLV-I Antibodies / blood
  • HTLV-I Infections / epidemiology*
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood
  • Herpesviridae Infections / epidemiology*
  • Herpesvirus 8, Human / immunology*
  • Humans
  • Lymphoma, T-Cell / epidemiology*
  • Male
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Infectious / epidemiology*
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral
  • HIV Antibodies
  • HTLV-I Antibodies
  • Hepatitis C Antibodies